Evans David T, Chen Li-Mei, Gillis Jacqueline, Lin Kuei-Chin, Harty Brian, Mazzara Gail P, Donis Ruben O, Mansfield Keith G, Lifson Jeffrey D, Desrosiers Ronald C, Galán Jorge E, Johnson R Paul
New England Regional Primate Research Center, Harvard Medical School, One Pine Hill Drive, Southborough, MA 01772-9102, USA.
J Virol. 2003 Feb;77(4):2400-9. doi: 10.1128/jvi.77.4.2400-2409.2003.
Nearly all human immunodeficiency virus (HIV) infections are acquired mucosally, and the gut-associated lymphoid tissues are important sites for early virus replication. Thus, vaccine strategies designed to prime virus-specific cytotoxic T lymphocyte (CTL) responses that home to mucosal compartments may be particularly effective at preventing or containing HIV infection. The Salmonella type III secretion system has been shown to be an effective approach for stimulating mucosal CTL responses in mice. We therefore tested DeltaphoP-phoQ attenuated strains of Salmonella enterica serovar Typhimurium and S. enterica serovar Typhi expressing fragments of the simian immunodeficiency virus (SIV) Gag protein fused to the type III-secreted SopE protein for the ability to prime virus-specific CTL responses in rhesus macaques. Mamu-A01(+) macaques were inoculated with three oral doses of recombinant Salmonella, followed by a peripheral boost with modified vaccinia virus Ankara expressing SIV Gag (MVA Gag). Transient low-level CTL responses to the Mamu-A01 Gag(181-189) epitope were detected following each dose of Salmonella. After boosting with MVA Gag, strong Gag-specific CTL responses were consistently detected, and tetramer staining revealed the expansion of Gag(181-189)-specific CD8(+) T-cell responses in peripheral blood. A significant percentage of the Gag(181-189)-specific T-cell population in each animal also expressed the intestinal homing receptor alpha4beta7. Additionally, Gag(181-189)-specific CD8(+) T cells were detected in lymphocytes isolated from the colon. Yet, despite these responses, Salmonella-primed/MVA-boosted animals did not exhibit improved control of virus replication following a rectal challenge with SIVmac239. Nevertheless, this study demonstrates the potential of mucosal priming by the Salmonella type III secretion system to direct SIV-specific cellular immune responses to the gastrointestinal mucosa in a primate model.
几乎所有人类免疫缺陷病毒(HIV)感染都是通过黏膜获得的,而肠道相关淋巴组织是病毒早期复制的重要部位。因此,旨在引发归巢至黏膜区室的病毒特异性细胞毒性T淋巴细胞(CTL)反应的疫苗策略,在预防或控制HIV感染方面可能特别有效。沙门氏菌III型分泌系统已被证明是刺激小鼠黏膜CTL反应的有效方法。因此,我们测试了肠炎沙门氏菌鼠伤寒血清型和伤寒沙门氏菌的缺失PhoP-PhoQ减毒株,它们表达与III型分泌的SopE蛋白融合的猿猴免疫缺陷病毒(SIV)Gag蛋白片段,以评估其在恒河猴中引发病毒特异性CTL反应的能力。给Mamu-A01(+)猕猴口服三剂重组沙门氏菌,随后用表达SIV Gag的安卡拉痘苗病毒(MVA Gag)进行外周加强免疫。每次给予沙门氏菌后,均检测到对Mamu-A01 Gag(181 - 189)表位的短暂低水平CTL反应。用MVA Gag加强免疫后,持续检测到强烈的Gag特异性CTL反应,四聚体染色显示外周血中Gag(181 - 189)特异性CD8(+) T细胞反应扩增。每只动物中相当比例的Gag(181 - 189)特异性T细胞群体也表达肠道归巢受体α4β7。此外,在从结肠分离的淋巴细胞中检测到Gag(181 - 189)特异性CD8(+) T细胞。然而,尽管有这些反应,经沙门氏菌引发/MVA加强免疫的动物在用SIVmac239进行直肠攻击后,并未表现出对病毒复制的更好控制。尽管如此,本研究证明了沙门氏菌III型分泌系统进行黏膜引发在灵长类动物模型中引导SIV特异性细胞免疫反应至胃肠道黏膜的潜力。